# FDA Inspection 1187347 - Hemarus LLC - November 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/hemarus-llc/8fe59499-b3db-4d7a-9684-2ff75fdb688e
Source feed: FDA_Inspections

> FDA Inspection 1187347 for Hemarus LLC on November 04, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187347
- Company Name: Hemarus LLC
- Inspection Date: 2022-11-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1234618 - 2024-04-30](https://www.keypedia.com/records/fda_inspections/hemarus-llc/77674ace-ff97-4ad1-80bd-769e8481a0e7)
- [FDA Inspection 1187347 - 2022-11-04](https://www.keypedia.com/records/fda_inspections/hemarus-llc/0f68d548-a9ca-49b4-878e-97795367106b)

Company: https://www.keypedia.com/companies/hemarus-llc/7e3cb278-9e15-4ba3-a74b-b27e6993381b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d